Pronóstico de adenocarcinoma esofagogástrico

1. C.S. Lin, S.C. Chang, Y.H. Wei, et al. Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg, 87 (2009), pp. 1056–1065
2. C.E. DeSantis, C.C. Lin, A.B. Mariotto, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin, 64 (2014), pp. 252–271
3. S.M. Lagarde, S.J. Franssen, J.R. van Werven, et al. Patient preferences for the disclosure of prognosis after esophagectomy for cancer with curative intent. Ann Surg Oncol, 15 (2008), pp. 3289–3298
4. T.W. Rice, V.W. Rusch, H. Ishwaran, et al. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union against Cancer Cancer Staging Manuals. Cancer, 116 (2010), pp. 3763–3773
5. T.W. Rice, V.W. Rusch, C. Apperson-Hansen, et al. Worldwide esophageal cancer collaboration. Dis Esophagus, 22 (2009), pp. 1–8
6. R.M. Levy, J.D. Luketich. Minimally invasive intrathoracic esophagogastric anastomosis. Semin Thorac Cardiovasc Surg, 22 (2010), pp. 256–258
7. A. Pennathur, O. Awais, J.D. Luketich. Technique of minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg, 89 (2010), pp. S2159–S2162
8. T.J. Murphy, R.M. Levy, L.R. Crist, et al. Minimally invasive pyloroplasty. Semin Thorac Cardiovasc Surg, 22 (2010), pp. 338–340
9. J.D. Luketich, M. Alvelo-Rivera, P.O. Buenaventura, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg, 238 (2003), pp. 486–494 discussion, 494–5
10. S. Ueno, G. Tanabe, K. Sako, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology, 34 (2001), pp. 529–534
11. P.K. Hsu, Y.C. Wu, T.Y. Chou, et al. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg, 89 (2010), pp. 1024–1031
12. E.S. Kassis, A.A. Vaporciyan, S.G. Swisher, et al. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population J Thorac Cardiovasc Surg, 138 (2009), pp. 412–418.e1–2
13. F.E. Harrell Jr., K.L. Lee, D.B. Mark. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med, 15 (1996), pp. 361–387
14. U.B. Mogensen, H. Ishwaran, T.A. Gerds. Evaluating random forests for survival analysis using prediction error curves. J Stat Softw, 50 (2012), pp. 1–23
15. N. Rizk, E. Venkatraman, B. Park, et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg, 132 (2006), pp. 1374–1381
16. J.D. Roder, R. Busch, H.J. Stein, et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg, 81 (1994), pp. 410–413
17. C.G. Peyre, J.A. Hagen, S.R. DeMeester, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg, 248 (2008), pp. 549–556
18. N.P. Rizk, H. Ishwaran, T.W. Rice, et al. Optimum lymphadenectomy for esophageal cáncer. Ann Surg, 251 (2010), pp. 46–50
19. J.D. Luketich, A. Pennathur, O. Awais, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg, 256 (2012), pp. 95–103
20. R.P. Merkow, K.Y. Bilimoria, W.B. Chow, et al. Variation in lymph node examination after esophagectomy for cancer in the United States. Arch Surg, 147 (2012), pp. 505–511
21. W. Hofstetter, A.M. Correa, N. Bekele, et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg, 84 (2007), pp. 365–373 discussion, 374–5
22. J.A. Hagen, S.R. DeMeester, J.H. Peters, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg, 234 (2001), pp. 520–530 discussion, 530–1
23. P. Gaur, W.L. Hofstetter, B.N. Bekele, et al. Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems. Ann Thorac Surg, 89 (2010), pp. 1797–1803 1804.e1–3; discussion, 1803–4
24. A. Pennathur, W.E. Gooding, K.S. Nason, et al. Survival is not significantly different in stage II subsets (of the AJCC 6th edition) after minimally invasive esophagectomy for esophageal cáncer. Ann Surg (2015) [Epub ahead of print]
25. B.H. von Rahden, H.J. Stein, M. Feith, et al. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction. J Clin Oncol, 23 (2005), pp. 874–879
26. W.H. Chen, Y.L. Huang, Y.K. Chao, et al. Prognostic significance of lymphovascular invasion in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol, 22 (2015), pp. 338–343
27. M.S. Landau, S.M. Hastings, T.J. Foxwell, et al. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol, 27 (2014), pp. 1578–1589
28. A. Pennathur, L. Xi, V.R. Litle, et al. Gene expression profiles in esophageal adenocarcinoma predict survival after resection. J Thorac Cardiovasc Surg, 145 (2013), pp. 505–512 discussion, 512–3
29. C.A. Ong, J. Shapiro, K.S. Nason, et al. Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma. J Clin Oncol, 31 (2013), pp. 1576–1582
30. J.M. Davison, M. Yee, J.M. Krill-Burger, et al. The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma. PLoS One, 9 (2014), p. e79079
31. J.M. Davison, S.T. Ellis, T.J. Foxwell, et al. MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas. Hum Pathol, 45 (2014), pp. 540–548
32. J. Park do, C. Yoon, N. Thomas, et al. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers. Ann Surg Oncol, 21 (2014), pp. 1130–1137
33. U. Malhotra, A.H. Zaidi, J.E. Kosovec, et al. Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium. PLoS One, 8 (2013), p. e78343
34. D. Rades, A. Bajrovic, S.E. Schild, et al. Biologic factors associated with tumor oxygenation are prognostic in patients with stage III esophageal cancer: long-term results. Anticancer Res, 34 (2014), pp. 4351–4355
35. S. Matsuda, H. Takeuchi, H. Kawakubo, et al. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score. Ann Surg Oncol, 22 (2015), pp. 302–310
36. A.D. Singhi, T.J. Foxwell, K. Nason, et al. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival. Am J Surg Pathol, 39 (2015), pp. 487–495